TopFunds

Drug Manufacturers General

Companies

11 companies

LIST VIEW

11 companies
Valuation
Historical Performance:
Fundamentals
Sort by:
01
Eli Lilly And Co LLY

1,273.5 (-2.5)%

42.7
1.8%
-
-
-
18.4%
77.8%

1.6

02
Johnson & Johnson JNJ

263.9 (-1.4)%

40
1.6%
-
-
-
13.5%
32.9%

-

03
AbbVie Inc. ABBV

285.6 (+0.1)%

80.5
3.6%
-
-
-
3.2%
(130.9)%

3.3

04
Merck & Co., Inc. MRK

145.3 (-1.3)%

116.2
4.5%
-
-
-
13.3%
34.7%

2.4

05
Amgen Inc. AMGN

439.3 (-1.8)%

27.3
4.3%
-
-
-
8.5%
89.1%

3.5

06
Gilead Sciences, Inc. GILD

156 (-0.7)%

(58.4)
6.8%
-
-
-
14.4%
37.6%

1.7

07
Novo Nordisk A/S NVO

39 (-1)%

9.9
4.2%
-
-
-
18.9%
52.8%

0.7

08
Pfizer Inc. PFE

30 (-1.3)%

39.7
6.4%
-
-
-
3.7%
9%

4.6

09
Bristol-Myers Squibb Company BMY

61.5 (-2.4)%

13.5
9.1%
-
-
-
7.8%
38.1%

2.7

10
Biogen BIIB

250.7 (-1.2)%

44.4
8%
-
-
-
4.4%
7.1%

2.5

11
Zoetis ZTS

81 (-1.2)%

13.3
6.7%
-
-
-
17.3%
80.3%

2.7

Total
Help

Assumes equal weights for the Base and Lens views. The Holdings view is position-weighted.

(-1.4)%
33.6
5.2%
277.1%
0%
0%
11.2%
29.8%
2.3